SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 4, 2026

CATX

Perspective Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $243K total
Actionable Insight • Neutral

The sales are immaterial in size and involve only 10% owner entities, not C-suite. No read-through for business fundamentals. Monitor for larger dispositions by Lantheus, which could signal changing strategic interest, but the current cluster is noise.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
CATX ▼ -24.36% at T+20d
NEUTRAL call -24.36% · α vs SPY -26.07% · entry $3.12 → $2.36
Next anchor: T+60d in 5w
Latest observation: T+34 -61.23% FF3 residual α
Entry = T+0 close
Sep 4, 2026
via day close
T+1d
-4.17%
call -4.17% · α -3.70%
$2.99
settled 7w ago
T+5d
-12.50%
call -12.50% · α -11.38%
$2.73
settled 6w ago
T+20d
-24.36%
call -24.36% · α -26.07%
$2.36
settled 22d ago
T+60d
Pending
in 5w

Price Chart

Loading chart...

Executive Summary

Two 10% owner entities (Lantheus Holdings, Inc. and Lantheus Alpha Therapy, LLC) sold a combined ~$243K in open-market transactions over two days. The dollar value is trivial relative to CATX's $356M market cap (~0.07%), and no C-suite insiders participated, making this a routine liquidity-driven event with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$242.8K
Insiders
2

Key Facts

  • Two 10% owner entities (Lantheus Holdings, Inc. and Lantheus Alpha Therapy, LLC) sold shares in open-market transactions on Sep 1-2, 2026
  • Total sales value: ~$243K (~0.07% of $356M market cap)
  • No C-suite insiders traded — all sellers are 10% owner affiliates
  • Lantheus Alpha Therapy also sold additional shares on Aug 31 (not included in the primary filing window total), bringing the broader 7-day Lantheus entity total to ~$845K

Financial Impact

~$243K in open-market sales by 10% owners, or ~0.07% of market cap

insider ownership

Risk Factors

  • Lantheus entities are a large holder — sustained selling would be more significant
  • Historical insider selling over 30d totals $846K, adding modest context but still small relative to market cap

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CATX-1788588343778
24 reports for CATX
Performance horizon
33% Hit rate @ T+20 1 of 3 directional calls Went positive at some point 3 of 5 best @ T+60▲ +5.76%Jun 12, 2026
Filters
Rows
Reports for CATX — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
8-K
BULLISH ★ 6/10
$1.61awaiting T+20—$1.19 (−26.09%)
Oct 8, 2026
19d ago
8-K
BULLISH ★ 6/10
$2.71awaiting T+20—$1.19 (−56.09%)
Oct 2, 2026
25d ago
Press Release
NEUTRAL ★ 3/10
$2.76awaiting T+20—$1.19 (−56.88%)
Sep 14, 2026
6w ago
8-K
BULLISH ★ 5/10
$2.92 $2.52▼ −13.70%▼ −15.96%$1.19 (−59.25%)
Sep 11, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$2.81 $2.66▼ −5.34%▼ −7.21%$1.19 (−57.65%)
Sep 8, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$2.99 $2.46▼ −17.73%▼ −19.67%$1.19 (−60.20%)
Sep 4, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.12 $2.36▼ −24.36%▼ −26.07%$1.19 (−61.86%)
Sep 4, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.12 $2.36▼ −24.36%▼ −26.07%$1.19 (−61.86%)
Aug 10, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$3.18 $2.99▼ −5.97%▼ −4.92%$1.19 (−62.58%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 4/10
$2.99 $3.20▲ +7.02%▲ +2.58%$1.19 (−60.20%)
Showing 10 of 24

US Market Status

Market Closed — Opens Wed (15h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 5, 2026